



Case Study: Drug testing in Nigeria
Title
Drug testing in Nigeria
Author
Spar, D; Day, A
Pages
19
Product Type
Reference #
9-706-033
Teaching Note
Institute
Setting
Nigeria
Year
2006
Keywords
Business and government; Business and society; Developing countries; Emerging markets; Ethics; Health care; International business; Risk
Summary/
Abstract
Abstract
In 1996, a meningitis epidemic swept across Nigeria. Thousands of children were struck and, lacking appropriate medicine, were liable to die from the disease. Doctors at Pfizer had an antibiotic that could probably save most of these children's lives. The drug was new, however, and had not yet undergone clinical trials with children. The company must decide whether to use the Nigerian outbreak as the site for a new and potentially risky trial.






